Education
About Us
Working with TipRanks
Follow Us
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
Nmra-323511
Alzheimer's Disease, Healthy Elderly
Phase I
Recruiting
Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease
Aug 06, 2024
―
Nmra-335140 80 Mg
Major Depressive Episode Associated With Bipolar Ii Disorder
Phase II
Completed
To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.
May 21, 2024
―
Nmra-335140
Major Depressive Disorder
Phase III
Recruiting
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
Sep 21, 2023
―
Nmra-335140
Major Depressive Disorder
Phase III
Recruiting
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder
Sep 21, 2023
―
Nmra-335140
Major Depressive Disorder
Phase III
Completed
Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
Sep 01, 2023
―
Nmra-335140
Major Depressive Disorder
Phase III
Recruiting
Study to Assess the Safety and Effectiveness of NMRA-335140-501
Sep 01, 2023
―
Nmra-335140
Major Depressive Disorder
Phase II
Completed
Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo
Jan 06, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Neumora Therapeutics, Inc. (NMRA) have in its pipeline
NMRA is currently developing the following drugs: Nmra-323511, Nmra-335140 80 Mg, Nmra-335140. These drug candidates are in various stages of clinical development as the company works toward FDA approval.